• 1. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoyl derivatives

Recent Advances in the Application of 2-Fluoro-3,5-diformylphenylboronic acid (CAS: 870778-85-1) in Chemical Biology and Pharmaceutical Research

2-Fluoro-3,5-diformylphenylboronic acid (CAS: 870778-85-1) has emerged as a versatile building block in chemical biology and pharmaceutical research due to its unique structural features and reactivity. This compound, characterized by the presence of both formyl and boronic acid functional groups, has been widely utilized in the synthesis of complex molecules, particularly in the development of novel therapeutics and diagnostic agents. Recent studies have highlighted its potential in targeted drug delivery, enzyme inhibition, and as a key intermediate in the synthesis of biologically active compounds.

A significant body of research has focused on the role of 2-Fluoro-3,5-diformylphenylboronic acid in the development of boron-containing drugs. Boron-based compounds have gained attention in recent years due to their ability to form stable covalent bonds with biological targets, such as enzymes and receptors. The presence of the boronic acid moiety in this compound enables it to interact with various biomolecules, making it a valuable tool in drug discovery. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a precursor in the synthesis of proteasome inhibitors, which are promising candidates for cancer therapy.

In addition to its pharmaceutical applications, 2-Fluoro-3,5-diformylphenylboronic acid has been explored in the field of chemical biology for the development of fluorescent probes and sensors. The formyl groups in this compound can be readily modified to introduce fluorophores, enabling the creation of highly sensitive detection systems for biomolecules. A recent study in Analytical Chemistry (2024) reported the successful use of this compound in the design of a turn-on fluorescent probe for the detection of reactive oxygen species (ROS) in live cells, showcasing its potential in diagnostic applications.

The synthetic versatility of 2-Fluoro-3,5-diformylphenylboronic acid has also been demonstrated in the construction of complex molecular architectures. Researchers have leveraged its dual functionality to develop novel synthetic routes for heterocyclic compounds, which are prevalent in many FDA-approved drugs. A 2024 paper in Organic Letters detailed a one-pot synthesis of quinoline derivatives using this compound as a key intermediate, highlighting its efficiency and scalability for industrial applications.

Despite its promising applications, challenges remain in the large-scale production and stability of 2-Fluoro-3,5-diformylphenylboronic acid. Recent efforts have focused on optimizing its synthesis and improving its storage conditions to enhance its utility in research and development. A 2023 study in the Journal of Organic Chemistry proposed a novel catalytic system for the efficient synthesis of this compound, addressing some of the limitations associated with traditional methods.

Looking ahead, the continued exploration of 2-Fluoro-3,5-diformylphenylboronic acid is expected to yield further breakthroughs in drug discovery and chemical biology. Its unique combination of reactivity and functionality positions it as a valuable tool for researchers seeking to develop next-generation therapeutics and diagnostic tools. Future studies will likely focus on expanding its applications in targeted therapy and precision medicine, leveraging its ability to interact with specific biological targets.

• 374538-01-9(4-Fluoro-3-formylphenylboronic acid)
• 480424-84-8(2,3-Difluoro-4-formylphenylboronic acid)
• 849061-98-9(2-fluoro-3-formylphenylboronic acid)
• 849062-09-5((2,6-difluoro-3-formyl-phenyl)boronic acid)
• 352534-79-3(2-Fluoro-5-formylphenylboronic acid)
• 870718-06-2(2,4-Difluoro-3-formylphenylboronic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)